These data show that digitoxin suppresses signaling by both TNFα/NFκB and TGFβ/TGFBR2 pathways in castration resistant prostate cancer cells, both in vitro and in vivo, and that an important consequence is significant suppression of EMT, tumor progression and tumor recurrence. This evidence concerns the gene NFKB1 and prostate carcinoma.